On ECHEMI
Home > Drugs > Yangzhou Zhongbao Pharmaceutical Co., Ltd.
Yangzhou Zhongbao Pharmaceutical Co., Ltd.
  • Founded in:

    1991-11-15
  • Country:

    China China
  • Address:

    No. 91, Baoying Avenue, New District, Economic Development Zone, Baoying County, Yangzhou City, Jiangsu Province
  • Tax NO.:

    91321000608709261R
  • Registered Funds:

    60 million yuan
  • Website:

  • Email:

Related Drugs
Cycloadenosine meglumine injection
The main ingredient of this product is cyclic adenosine monophosphate meglumine, which is the salt of cyclic adenosine monophosphate and meglumine (molar ratio 1:1).
Name Description Content CAS NO. Registered Holders
cAMP

Non-digitalis cardiotonic agent with positive inotropic effect, can enhance myocardial contractility, improve cardiac pumping function, dilate blood vessels, reduce myocardial oxygen consumption; improve myocardial cell metabolism, protect ischemic and hypoxic myocardium; can improve sinoatrial node P cell function.

More

Non-digitalis cardiotonic agent with positive inotropic effect, can enhance myocardial contractility, improve cardiac pumping function, dilate blood vessels, reduce myocardial oxygen consumption; improve myocardial cell metabolism, protect ischemic and hypoxic myocardium; can improve sinoatrial node P cell function.

0
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Ondansetron Hydrochloride Injection
The main ingredient of this product is ondansetron hydrochloride, and its chemical name is: 2,3-dihydro-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-4(1H)-carbazolone hydrochloride dihydrate.
Name Description Content CAS NO. Registered Holders
Ondansetron hydrochloride

This product is a selective 5-HT3 receptor antagonist, which may block the vomiting reflex caused by chemotherapy and surgery that promotes the release of 5-HT from intestinal chromaffin cells and excites vagal afferent nerves by antagonizing 5-HT3 receptors in peripheral vagal nerve endings and central chemoreceptor areas. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

More

This product is a selective 5-HT3 receptor antagonist, which may block the vomiting reflex caused by chemotherapy and surgery that promotes the release of 5-HT from intestinal chromaffin cells and excites vagal afferent nerves by antagonizing 5-HT3 receptors in peripheral vagal nerve endings and central chemoreceptor areas. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

103639-04-9 26
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.